NCT00049777View on ClinicalTrials.gov

A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)

PHASE4CompletedINTERVENTIONAL

Enrollment

2,000

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

August 31, 2005

Conditions

Sepsis

Interventions

DRUG

Drotrecogin Alfa (Activated)

DRUG

Unfractionated heparin

DRUG

Low molecular weight heparin

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician, Berlin

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00049777 - A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated) | Biotech Hunter | Biotech Hunter